Moderna's First Vaccine Was a Big Hit. Its Second Is a Let Down

A scientist works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. The forthcoming RSV shot, expected to get US regulatory approval this month, is Moderna's first chance to show the versatility of mRNA technology to more effectively treat and prevent a range of illnesses from the flu to cancer. It will be the first mRNA product for something other than Covid. Photographer: Adam Glanzman/Bloomberg via Getty Images

Moderna's First Vaccine Was a Big Hit. Its Second Is a Let Down
A scientist works in the lab at the Moderna Inc. headquarters in Cambridge, Massachusetts, US, on Tuesday, March 26, 2024. The forthcoming RSV shot, expected to get US regulatory approval this month, is Moderna's first chance to show the versatility of mRNA technology to more effectively treat and prevent a range of illnesses from the flu to cancer. It will be the first mRNA product for something other than Covid. Photographer: Adam Glanzman/Bloomberg via Getty Images
PURCHASE A LICENSE
How can I use this image?
$375.00
USD
Getty ImagesModerna's First Vaccine Was a Big Hit. Its Second Is a Let Down, News PhotoModerna's First Vaccine Was a Big Hit. Its Second Is a Let Down, News PhotoModerna's First Vaccine Was a Big Hit. Its Second Is a Let Down Get premium, high resolution news photos at Getty ImagesProduct #:2151784870
$499$175
Getty Images
In stock

DETAILS

Credit: Bloomberg / Contributor

Getty Images editorial coverage is captured by expert trusted visual journalists. Learn more about our editorial policies.


Restrictions:
Contact your local office for all commercial or promotional uses.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Editorial #:
2151784870
Collection:
Bloomberg
Date created:
March 26, 2024
Upload date:
License type:
Release info:
Not released. More information
Source:
Bloomberg
Object name:
MODERNA RSV VACCINE
Max file size:
5646 x 3764 px (18.82 x 12.55 in) - 300 dpi - 4 MB